Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Clinical Trial

Overview of attention for article published in Ophthalmology, April 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 3 X users

patent: 4 patents

Readers on

mendeley: 129 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 29,776 followers.

.@BascomPalmerEye @OCBeyeboston @UniBonn https://t.co/9xhw4FR3LU

Emixustat hydrochloride, orally administered small molecule inhibiting visual cycle isomerohydrolase, RPE65, does NOT reduce growth of geographic atrophy in age-related #maculardegeneration. 2yr study included 320 patients randomized to emixustat, place…

Emixustat Hydrochloride for Geographic Atrophy Secondary to #AMD @AAOjournal | #ECM https://t.co/F0ODJ7ncoO

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.